Targeted Mitochondrial ECSIT Overexpression Attenuates MASH by Increasing OTUD3 Expression

Area of Science:

• Hepatology
• Mitochondrial Biology
• Metabolic Disorders

Background:

• Mitochondrial dysfunction is central to metabolic dysfunction-associated steatohepatitis (MASH) pathogenesis.
• The role of ECSIT (Endothelial cell-selective adhesion molecule interacting protein) in mitochondria, particularly concerning oxidized mitochondrial DNA, remains incompletely understood.
• Understanding ECSIT's function in MASH is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the role and impact of mitochondrial ECSIT expression in mouse models of MASH.
• To elucidate the molecular mechanisms by which ECSIT influences MASH progression.
• To assess the therapeutic potential of targeting mitochondrial ECSIT.

Main Methods:

• Utilized mitochondria-targeted ECSIT transgenic (ECSIT MTG) mice and wild-type (WT) controls.
• Administered high-fat, high-cholesterol (HFHC) diet for 16 weeks or methionine- and choline-deficient (MCD) diet for 8 weeks to induce MASH phenotypes.
• Analyzed mitochondrial ECSIT expression and its downstream effects on key proteins and metabolic parameters.

Main Results:

• Mitochondrial ECSIT overexpression significantly alleviated diet-induced MASH phenotypes in mouse models.
• ECSIT promoted the mitochondrial localization of the deubiquitinase OTUD3.
• OTUD3 stabilized SIRT3 through deubiquitination, leading to inhibition of mitochondrial DNA oxidation and reduced steatosis.

Conclusions:

• Mitochondrial ECSIT plays a protective role against MASH progression.
• The ECSIT-OTUD3-SIRT3 axis is a key pathway for mitigating mitochondrial dysfunction and metabolic disorders in MASH.
• Targeting mitochondrial ECSIT represents a promising therapeutic strategy for MASH.